Ctrl Therapeutics

Developer of therapeutics for solid tumor treatments

placeSan Francisco, California, United States calendar_todayFounded 2022 language ctrl-tx.com

Investor mix

4 investors on record; lead investors include General Catalyst.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon